Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases

Anima Biotech said that it reached a strategic collaboration with Takeda Pharmaceutical Company Limited to discover and develop a new class of medicines for genetically-defined neurological diseases.